Quidel | QDEL - Ebitda


Quidel reported $129.3M in EBITDA for its fiscal quarter ending in June of 2026.





Ebitda Change Date
Abbott USD 2.43B 844M Mar/2026
Agilent USD 456M 84M Dec/2025
Becton, Dickinson and Co. USD 1.71B 1B Jun/2026
Bruker USD 143.2M 33.2M Jun/2026
Charles River Laboratories USD 272.95M 43.14M Jun/2026
Danaher USD 1.84B 81M Jun/2026
Haemonetics USD 96.17M 91.87M Jun/2026
Illumina USD 330M 80M Jun/2026
IQVIA Holdings USD 994M 62M Jun/2026
Merit Medical Systems USD 104.39M 10.97M Jun/2026
Mettler Toledo International USD 322.64M 43.66M Jun/2026
Myriad Genetics USD 14.3M 4M Dec/2025
Neogen USD 45.4M 2.8M Mar/2026
OraSure Technologies USD -17.7M 4.06M Dec/2025
Pacific Biosciences Of California USD -35.4M 5.78M Sep/2025
Quidel USD 129.3M 20.6M Jun/2026
Revvity USD 228.18M 44.73M Jun/2026
STAAR Surgical USD -159K 34.78M Dec/2025
Thermo Fisher Scientific USD 3.55B 845M Jun/2026
Waters USD 712M 545M Jun/2026